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ABSTRACT
Objective To investigate the degree to which ionising
radiation confers risk of mortality from heart disease and
stroke.
Design Prospective cohort study with more than 50 years
of follow-up.
Setting Atomic bomb survivors in Hiroshima and
Nagasaki, Japan.
Participants86611LifeSpanStudycohortmemberswith
individually estimated radiation doses from 0 to >3 Gy
(86% received <0.2 Gy).
Main outcome measures Mortality from stroke or heart
disease as the underlying cause of death and dose-
response relations with atomic bomb radiation.
Results About 9600 participants died of stroke and 8400
diedofheartdiseasebetween1950and2003.Forstroke,
the estimated excess relative risk per gray was 9% (95%
confidence interval 1% to 17%, P=0.02) on the basis of a
lineardose-responsemodel,butanindicationofpossible
upward curvature suggested relatively little risk at low
doses. For heart disease, the estimated excess relative
risk per gray was 14% (6% to 23%, P<0.001); a linear
model provided the best fit, suggesting excess risk even
at lower doses. However, the dose-response effect over
the restricted dose range of 0 to 0.5 Gy was not
significant. Prospective data on smoking, alcohol intake,
education, occupation, obesity, and diabetes had almost
noimpact onthe radiation riskestimates foreither stroke
or heart disease, and misdiagnosis of cancers as
circulatory diseases could not account for the
associations seen.
Conclusion Doses above 0.5 Gy are associated with an
elevated risk of both stroke and heart disease, but the
degree of risk at lower doses is unclear. Stroke and heart
disease together account for about one third as many
radiation associated excess deaths as do cancers among
atomic bomb survivors.
INTRODUCTION
The effects of radiation on incidence of or mortality
from circulatory disease have large implications for
public health, especially if effects occur at doses
under1Gy.Giventhatthefrequencyofmultiplecom-
puted tomography scans of the head or chest and of
interventional radiographic procedures is increasing
rapidly, information on whether these may confer
risk for subsequent stroke or heart disease is essential.
Several studies, including randomised controlled
trials, have found that high doses of radiation to the
heart from radiotherapy for Hodgkin’s disease or
breast cancer cause an excess of deaths from heart dis-
ease in later years,
1-4 and other studies have suggested
that radiotherapy for Hodgkin’s disease, childhood
leukaemiaorbraintumours,andheadandneckcancer
increasestheriskofstroke.
5-8Severalauthorshavesug-
gested that lower doses from occupational, medical,
and environmental exposures may be associated with
excess mortality from circulatory disease,
9-14 although
other studies have not found such low dose effects,
15-19
and information on doses and potential confounding
lifestyle factors is limited in many of the studies of
low doses. We examined the dose-response informa-
tion on the risk of heart disease and stroke in the large
Life Span Study cohort of atomic bomb survivors in
Hiroshima and Nagasaki who have been followed up
for 53 years, from 1950 to 2003.
METHODS
Study population
TheLifeSpanStudycohort,definedonthebasisofthe
Japanese national census in 1950 and special surveys
between 1950 and 1953, consists of 86611 atomic
bomb survivors with estimated radiation doses. It
includes a large proportion of the survivors who were
within 2.5 km of the hypocentres at the time of the
bombings and still resided in Hiroshima or Nagasaki
in1950,plusa randomageandsexmatched sampleof
people 2.5 to 10 km from the hypocentre who sus-
tained small to negligible radiation doses.
20 This
study population was of all ages and both sexes at the
time of the bombings.
Individual doses have been carefully estimated
using the recent improved DS02 dosimetry system,
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ing at the time of the atomic bomb.
2122 We estimated
risksby usingweightedcolondosesingray(Gy)for all
analyses. We used weighted doses, the sum of the γ
dose plus 10 times the smaller neutron dose, to allow
for the greater biological effectiveness of neutrons.
Thefollow-upofvitalstatustookplacefrom1Octo-
ber 1950 to the end of 2003 and was based on the
nationwide obligatory family registration system
(koseki) that documents mortality and is virtually
100%complete.Causesofdeathcamefromtheofficial
vitalstatisticsdeathschedulesbasedonthedeathcerti-
ficates. Underlying and contributing causes of death
were classified according to the ICD-7 (international
classification of diseases, 7th revision) (for deaths in
1950-68), ICD-8 (in 1969-78), ICD-9 (in 1979-97),
andICD-10(in1998-2003).However,forthepurposes
of these analyses we converted them to ICD-9 codes
390-459 for all circulatory disease, 430-438 for stroke,
and 393-429 (excluding 401, 403, and 405) for heart
disease. We used only underlying causes of death in
the primary analyses but examined underlying plus
contributing causes in a subsidiary analysis.
Collection of covariate data and data from autopsy and
tumour registry
A mail survey was sent to a defined sub-cohort of
51965LifeSpanStudycohortmembersin1978.Infor-
mation was obtained from 36468 (response rate of
70%)onsociodemographic(education,typeofoccupa-
tion), lifestyle (smoking, alcohol intake), and health
variables (obesity, diabetes mellitus), which enabled
the evaluation of possible confounding by these vari-
ables. Between 1950 and 1985 autopsy data were also
availableonmorethan1900deathsthat hadanunder-
lying cause of circulatory disease on the death certifi-
cate, which permitted evaluation of diagnostic
accuracy. To identify pre-existing cases of cancer, we
used the Hiroshima and Nagasaki tumour registries
(availablesince1958)andtissueregistries(since1974).
Statistical analysis
We based the analyses on a detailed summary table of
the number of deaths and person years stratified by
dose, city, sex, and five year intervals of age at expo-
sure, attained age, and follow-up period. We divided
participants into categories according to the weighted
colon dose (in Gy=γ dose plus 10 times neutron dose):
0-, 0.005-, 0.02-, 0.04-, 0.06-, 0.08-, 0.1-, 0.125-, 0.15-,
0.175-, 0.2-, 0.25-, 0.3-,0.5-, 0.75-, 1-, 1.25-, 1.5-, 1.75-,
2-, 2.5-, and ≥3. As described elsewhere, we truncated
the colon doses to correspond to the 4 Gy shielded
kerma level,
20 but this affected only 317 participants.
We used Poisson regression methods for grouped
survival data to describe the dependence of risk on
radiation dose and to evaluate the variation of the
dose-response effects with respect to city, sex, age at
exposure, time since exposure, and attained age,
23
essentially identical to the methods used previously
to examine mortality from cancer in this cohort.
20 We
used Epicure software for parameter estimation and
tests,
24 and we based significance tests and 95% confi-
dence intervals on likelihood profiles.
The primary models used here are excess relative
risk (ERR) models of the form λ0 (c,s,a,b) [1+ERR (d,
e,s,a)], where λ0 () is the baseline, or background death
rate (that is, the rate for people with zero dose), which
depended on city (c), sex (s), attained age (a), and birth
year (b). The function ERR (d,e,s,a) describes the rela-
tive change in rates associated with dose (d), allowing
for the effects of sex, age at exposure (e), and attained
age. We examined effect modifiers by using models
corresponding to those in Preston et al.
2025 We exam-
ined both dose and dose squared terms to evaluate the
degree of linearity or curvature in the dose-response
forms. We also tested a linear threshold model. We
used differences in maximum likelihood to compare
nested models or the Akaike information criterion for
non-nested models.
26 We evaluated a linear threshold
modelrepeatedlyforawiderangeofpossiblevaluesof
a threshold dose (d0), modelling the risk function ERR
on doses d as β(d−d0) for d>d0 or d=0 for d≤d0.W e
empirically determined the values yielding the maxi-
mum likelihood and 95% confidence bounds.
We examined the impact of the possible confound-
ing factors of smoking (never, past, present <20/day,
present ≥20/day), alcohol intake (regular, seldom/
never), education (primary or less, secondary, col-
lege/university), occupation for household (profes-
sional/technical, clerical/sales, farmer/craftsman,
transportation/service), obesity (body mass index
<20, 20-24, ≥25), and diabetes (yes, no) on the esti-
mates of radiation risk, including codes for missing
information, for the Life Span Study participants
included in the 1978 mail survey. We included Cox-
type regression models fitted to the individual data,
where radiation dose was modelled as a linear excess
relative risk, and indicator variables for the potential
confounders jointly in the models as conventional
exponential relative risk terms by using the Peanuts
program in Epicure.
24
RESULTS
During follow-up, 19054 deaths from circulatory dis-
easeoccurredamongthe86611LifeSpanStudymem-
bers with DS02 dose available. Table 1 shows the
numbers of participants and deaths from circulatory
disease by age, sex, and radiation dose. The cohort
covers a wide range of doses but is weighted towards
lowdoses,whichindicatesthatithasconsiderablecap-
abilitytoexaminerisksatlowdosesandtoexaminethe
shapeofthedose-responsecurve.Thedeathsincluded
9622 from stroke, 8463 from heart disease, and 969
from other circulatory diseases. The excess relative
risk per Gy for all circulatory disease based on the lin-
ear model over the full dose range was 11% (95% con-
fidence interval 5% to 17%, P<0.001). This represents
about 210 excess cases of death from circulatory dis-
ease associated with the exposure to radiation.
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The excess relative risk per Gy for stroke based on the
linear model over the full dose range was 9% (1% to
17%, P=0.02) (table 2). Figure 1 shows estimates of
the shape of the dose-response curve for all stroke,
includingthefittedlinearandlinear-quadraticmodels.
The test for non-linearity based on a comparison of
linear and linear-quadratic dose-response models was
not statistically significant (P=0.17),but the purequad-
raticmodel,whichsuggestsrelativelylittleriskatlower
doses, nominally provided a slightly better fit (differ-
ence in Akaike information criterion statistics of 1.87)
than did the linear model. This was confirmed by ana-
lyses of lower dose ranges which showed excess rela-
tive risk per Gy of 3% (−10% to 16%) for 0-1 Gy and
−7% (−28% to 16%) for 0-0.5 Gy. Figure 1 also shows
no apparent risk for the lower part of the dose range; a
non-negligible threshold may exist below which no
excess occurs. The best estimate of a threshold dose
was 0.5 Gy with an upper 95% confidence limit of
about 2 Gy. However, the lower 95% confidence
limit was not greater than 0, so no threshold dose
may exist.
Ananalysisofeffectmodificationoftheriskofstroke
by sex, attained age, and age at exposure showed a
statistically significant difference for attained age
(P=0.04): the radiation excess relative risk per Gy for
stroke was higher before age 60 than after, especially
amongmen(webtableA).Wealso founda non-signif-
icant indication (P=0.23) that the risk of stroke asso-
ciated with radiation may be highest after exposure at
young ages: the excess relative risk per Gy were 36%,
9%, 15%, and 5% for ages <10, 10-19, 20-39, and ≥40.
Anevaluationofsubtypesofstrokewasnotverymean-
ingful because, before the 1990s, differential diagnosis
was often not done, resultingin many cases being clas-
sified as stroke, not otherwise specified.
Heart disease
The excess relative risk per Gy for all heart disease
based on the linear model in the full dose range was
14% (6% to 23%, p<0.001) (table 2). Figure 2 shows
the results for the linear and linear-quadratic models.
The test for non-linearity based on a comparison of
linear and linear-quadratic dose-response models was
notstatisticallysignificant(P>0.5).Apurelinearmodel
fitted the data nominally better than did a pure dose-
squared model (difference in Akaike information cri-
terion statistics of 2.47). The excess relative risks per
Gy for heart disease over restricted dose ranges were
similar to that for the full dose range. Specifically, the
excess relative risk per Gy based on the linear model
for the dose ranges under 2, 1, and 0.5 Gy were 14%
(4% to 25%), 18% (3% to 33%), and 20% (−5% to 45%).
In figure 2, the slope over the lower part of the dose
rangewasalmostidenticaltotheonefortheentiredose
Table 1 |Number of participants and deaths from circulatory disease
Characteristics
No of people
(n=86 611)
No of deaths
Circulatorydisease
(n=19 054)
Stroke
(n=9 622)
Heart disease
(n=8 463)
Other circulatory
disease (n=969)
Sex:
Male 35 687 7 607 3 958 3 261 388
Female 50 924 11 447 5 664 5 202 581
Age at atomic bomb exposure (years):
0-9 17 833 428 176 238 14
10-19 17 563 951 404 508 39
20-29 10 891 1 551 652 831 68
30-49 25 774 9 712 4 735 4 575 402
≥50 14 550 6 412 3 655 2 311 446
Weighted colon radiation dose (mGy):
<5 38 509 8 440 4 247 3 723 470
5- 23 427 5 089 2 637 2 205 247
50- 12 508 2 838 1 405 1 305 128
200- 6 356 1 485 735 680 70
500- 3 424 745 363 342 40
1000- 1 763 341 176 158 7
≥2000 624 116 59 50 7
Weighted colon dose (Gy)
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Fig 1 | Radiation dose-response relation (excess relative risk
per Gy) for death from stroke, showing linear and linear-
quadratic functions. Shaded area is 95% confidence region
for fitted linear line. Vertical lines are 95% confidence
intervals for specific dose category risks. Point estimates of
risk for each dose category are indicated by circles
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with an upper 95% confidence limit of about 0.5 Gy.
We found no significant modification of effect by sex,
age at exposure, or age at risk (web table A).
Analyses of different subtypes of heart disease
revealed some diversity in dose-response effects (web
table B) but involve a variety of uncertainties, the
articulationofwhichisbeyondthescopeofthisreport.
The risk of ischaemic heart disease increased only in
the higher dose categories, and the linear increase was
not significant. We found stronger associations
between radiation and other heart diseases, such as
hypertensiveheartdiseaseandheartfailure.However,
unlike the relatively high accuracy in diagnosing the
generalcategoryofheartdisease,substantialmisclassi-
ficationofsubtypesofheartdiseaseoccurs(seebelow),
which limits the meaning that can be attached to the
analyses of subtypes.
Confounding factors and misdiagnosis
We examined the impact of the possible confounding
factors on the radiation risk estimates among the
51965 Life Span Study participants included in the
1978 mail survey. Table 3 shows the excess relative
risks unadjusted and adjusted for six potential con-
founding factors. Note that the excess relative risks in
table 3differslightlyfromthoseintable 2,becausethe
estimatesintable 3 arebased ononly thesubcohortof
theLifeSpanStudy,whereasthoseintable 2arebased
on the full cohort (86611 participants). Although
smoking, alcohol intake, education, type of occupa-
tion, obesity (body mass index), and diabetes were
risk factors for heart disease and stroke in their own
right (for example, the relative risks for heart disease
were 1.4 for smoking, 1.6 for diabetes, 1.1 for body
mass index 25 or over, and 0.75 for university educa-
tion), they showed virtually no confounding with dose
of radiation. That is, adjustment for the six variables
simultaneously produced inconsequential changes in
the excess relativerisk per Gy: only 0.1%for heartdis-
easeand−0.9%forstroke(table 3).Analyseslimitedto
respondents similarly showed little impact of the con-
founder variables (data not shown). These results sug-
gestthatintheLifeSpanStudy,theassociationsofdose
of radiation with mortality from stroke and heart dis-
ease is unlikely to be an artefact of confounding by
major lifestyle, sociodemographic, or disease risk
factors.
We also examined the diagnostic accuracy of death
certificates by comparing them with autopsy reports
amongthe1963caseswithdeathcertificatedesignated
circulatory disease for whom autopsies were available
from our autopsy programme between 1950 and
1985.
27 For the broad categories of stroke and heart
disease,theaccuracyofthediagnosesonthedeathcer-
tificates was fairly good. For death certificates with
stroke as the underlying cause of death, 86% of autop-
sies listed stroke as a cause; 92% of death certificates
with heart disease as the underlying cause had heart
disease listed as a cause on the autopsy report. More-
over, the accuracy of diagnoses on death certificates
has probably improved since 1985. However, the cor-
responding accuracy was rather poor for the differen-
tial diagnosis of specific subcategories of stroke or
heartdisease(forexample,65%forcerebralinfarction,
39% for cerebral haemorrhage, 69% for ischaemic
heart disease, 22% for hypertensive heart disease, and
64% for rheumatic heart disease); web table B shows
risk estimates for separate subcategories.
Deaths from circulatory disease based on death cer-
tificatesmayincludemisdiagnoseddeathsfromcancer
or cases arising from cardiotoxicity due to chemother-
apy or radiotherapy for cancer. To remove the effects
of misdiagnosis of cases of cancer, we estimated risks
after excluding people who had previous diagnoses of
cancer, on the basis of our tumour registry data. These
excess relative risks were reduced by about 30% com-
pared with estimates based on the full cohort, but still
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Fig 2 | Radiation dose-response relation (excess relative risk)
for death from heart disease, showing linear and linear-
quadratic functions. Shaded area is 95% confidence region
for fitted linear line. Vertical lines are 95% confidence
intervals for specific dose category risks. Point estimates of
risk for each dose category are indicated by circles
Table 2 |Summary excess relative risks (ERR)* per Gy and excess additive risks per 10
4 person year Gy† (EAR/10
4 PY-Gy) for
types of circulatory disease mortality
Circulatory
disease
Indicated as underlying cause of death Underlyingor contributingcauseof death
Deaths P value % ERR/Gy (95% CI) EAR/104PY-Gy(95%CI)† Deaths % ERR/Gy (95% CI)
Total 19 054 <0.001 11 (5 to 17) 5.5 (2.7 to 8.4) 25 113 15 (10 to 20)
Stroke 9 622 0.02 9 (1 to 17) 2.3 (0.4 to 4.4) 12 139 12 (5 to 19)
Heart disease 8 463 <0.001 14 (6 to 23) 3.2 (1.3 to 5.2) 14 018 18 (11 to 25)
Other 969 >0.5 2 (−18 to 29) 0.1 (−0.4 to 0.7) 5 846 58 (45 to 72)
*Estimates based on linear model, adjusted for city, sex, age at exposure, and attained age.
†Average EARs calculated directly from fitted ERR models.
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Excludingpreviouscasesofcancerchangedtheexcess
relativeriskperGyfrom10.8%to7.3%(dose-response
P=0.008) for all circulatory disease, from 8.8% to 6.2%
(P=0.11) for stroke, and from 14.0% to 9.5% (P=0.03)
for heart disease.
Although we used the designated underlying cause
of death in the mortality analyses, selecting a single
cause of death is difficult when several correlated dis-
easesorconditionscontributedtodeath.Therefore,we
examinedtherisksonthebasisofbothunderlyingand
contributing causes of death (table 2). The radiation
dose-response effects were nominally higher than
those based on underlying cause of death alone (12%
v 9% excess relative risk per Gy for stroke, and 18% v
14% for heart disease), which lends additional support
to the hypothesis of radiation risk.
DISCUSSION
This study found dose-response evidence for risk of
heartdiseaseandstrokeamongatomicbombsurvivors
over the radiation dose range 0-4 Gy (mostly 0-2 Gy)
based on well characterised individual doses and
essentially complete ascertainment of mortality over
the period of five to 58 years after exposure to radia-
tion. This report updates earlier brief reports of a dose
related excess of circulatory disease among atomic
bomb survivors.
202829 These results, based on about
25%moredeathsthanthepreviouspaper,aresubstan-
tially stronger, and we now provide more elaboration
of the associations.
Asshownintable 1,attheyoungestagesofexposure
(more recent birth cohorts) the deaths from heart dis-
ease outnumber those from stroke, whereas the oppo-
site is true of the earlier birth cohorts; this reflects the
general secular trends in the Japanese population. The
table also shows that the cohort covers a wide range of
dosesbutisweightedtowardlowdoses,indicatingthat
it has substantial capability to examine risks at low
doses and to examine the shape of the dose-response
curve. Because several plausible disease mechanisms
centre around systemic effects after whole body irra-
diation, we used colon doses as an approximation to
whole body doses for all analyses, although analyses
using brain dose for stroke and lung dose for heart dis-
ease produced very similar results (data not shown).
Summary of features and coherence of radiation risk data
Although the data were statistically consistent with
linearity over the full dose range in this study, consid-
erable uncertainty exists about the shape of the dose-
response curve in the low dose range. The extent of
curvature seemed to be larger for stroke than for
heart disease; a pure dose-squared model fitted the
stroke data slightly better than did a pure linear
model, whereas the linear model provided a better fit
for heart disease. However, the dose-response effect
was not statistically significant for either end point
when we limited the calculation to the dose range 0-
0.5 Gy, implying that evidence is limited on the risk
below about 0.5 Gy. For stroke, the estimated thresh-
old dose was 0.5 Gy, with an upper 95% confidence
limit of about 2 Gy. For heart disease, the estimated
threshold dose was 0 Gy, with an upper 95% confi-
dence limit of about 0.5 Gy.
Additional analyses supported the association of
radiation with stroke and heart disease. Adjustment
of the data for other potential risk factors for circula-
tory disease—obesity, diabetes, smoking, alcohol con-
sumption, education, and occupation—had almost no
impact on the associations with radiation, whereas an
analysis for possible misdiagnosis of cancer as circula-
tory disease showed a small diminution of radiation
risk. Because the underlying cause of death is often
uncertain, we also did analyses of stroke and heart dis-
ease indicated as either an underlying or contributing
cause; these showed nominally stronger associations
with radiation than did the analyses of underlying
cause alone.
The findings of the epidemiological study of circula-
tory disease among atomic bomb survivors are con-
firmed and extended by our Adult Health Study,
whichconsistsofbiennialclinicalandlaboratoryexam-
inationssince1958ofabout15%oftheLifeSpanStudy
cohort members. The Adult Health Study has found
dose related increases in the incidence of stroke and
myocardial infarction and in the incidence or preva-
lence of hypertension, elevated serum cholesterol con-
centrations, and aortic arch calcification.
30-35 Late
radiation effects have also been found for potential
biomarker precursors of circulatory disease, including
biomarkers for inflammation,
36-38 deficient immunolo-
gical responses,
39 and alterations in immune cell
repertoire.
4041Thefindingspresentareasonablycoher-
ent picture of preclinical and clinical risk of circulatory
disease associated with exposure to radiation. How-
ever, this needs to be complemented by a risk assess-
ment of low doses based on mechanistic and animal
models.
Strengths and limitations of study
This study has several strengths, including a large
population not pre-selected for existing disease or
occupational fitness, a wide but relatively low dose
range (0->3 Gy) and well characterised doses, a
53 year follow-up with virtually complete mortality
ascertainment, and corroborative evidence from
Table 3 |Effects of potential confounding factors on radiation risk estimates for types of
circulatory disease mortality
Circulatory disease No of deaths
% ERR/Gy unadjusted
for confounders*
% ERR/Gy adjusted
for all confounders*†
Total 7907 10.0 9.6
Stroke 3366 8.1 7.2
Heart disease 4204 12.2 12.3
Other 337 2.4 0.9
ERR=excess relative risks.
*All analyses adjusted for city, sex, age at exposure, and attained age.
†Additionally adjusted for smoking, alcohol intake, education, type of household occupation, obesity (body
mass index), and diabetes mellitus (on basis of about 52 000 participants).
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circulatory disease on a random subsample of the
cohort.
30-41 In addition, we believe medical surveil-
lance bias to be minimal, as all of the cohort is eligible
for free, special medical care, and many people have
littleideaofthedosestheyreceived,sothatthelevelof
radiation related medical concern is not highly corre-
lated with the actual dose received. In addition, the
analysesofradiationdosewithstrokeandheartdisease
mortality showed that the association is reasonably
robust with respect to confounding by lifestyle, socio-
demographic, or other health factors or misdiagnosis.
Thestudyalsohasseverallimitationsanduncertain-
ties. Ascertainment of circulatory disease from death
certificates is of limited diagnostic accuracy and repre-
sents only a fraction of cases of incident disease. Ana-
lyses for confounders, although very important, are
incomplete, lacking information on, for example,
blood lipids, physical activity, and nutrition. Some
selection effects due to dose related early mortality
from the bombs may have occurred, although the
impactoftheseislikelytobesmall.
42Otherlimitations
include unclear dose-response effects below about 0.5
Gy, inadequate information about possible biological
mechanisms, and uncertainty about the generalisabil-
ity of these results to Western populations because of
differences in genetic factors, dietary and lifestyle risk
factors, and baseline levels of risk for stroke and heart
disease.
43
Comparison with other studies
Although epidemiological and experimental data are
limited,severalstudiessuggestthepossibilityofeffects
of radiation on circulatory disease. Among medically
exposed cohorts, excess heart disease mortality has
been shown among patients who received radio-
therapy for Hodgkin’s lymphoma or breast
cancer.
1-444 At somewhat lower doses, an increase in
coronary heart disease was seen among patients who
receivedradiotherapyforpepticulcer.
9Anassociation
was also seen among patients with scoliosis who
received multiple fluoroscopic examinations,
45 but
not among patients with tuberculosis who received
multiple fluoroscopic examinations of the chest,
16 nor
among patients who received radiographic treatment
for benign gynaecological disease.
4647
Studiesofcohortswithoccupationalorenvironmen-
tal exposure to radiation have not provided clear evi-
dence for or against a radiation associated increase in
mortality from circulatory disease. In a long term fol-
low-up of early US radiologists, circulatory disease
mortality was higher than for a comparison group of
other medical specialists,
48 but a similar increase was
not seen among early UK radiologists.
17 Increased
mortality from circulatory disease was found among
US radiological technologists who worked before
1950, when radiation exposures tended to be higher,
but individual people’s doses were not documented.
10
Significant associations with radiation for both stroke
and heart disease were reported for emergency
workers at Chernobyl,
12 although the study may have
limitationsrelatedtosampleselectionandtovariations
in circulatory disease risk factors and medical surveil-
lance. Among workers for British Nuclear Fuels, a sig-
nificant dose-response association was found for
ischaemic heart disease but not cerebrovascular
disease.
13 No association was found between radiation
doseandcirculatorydiseasesamongGermanuranium
miners.
19 Preliminary results for the Mayak nuclear
workers show a statistically significant dose-response
association for ischaemic heart disease and stroke.
49
A new update of the UK national registry for radiation
workers shows a marginally positive association of
dose of radiation with heart disease, but further ana-
lysessuggestthatthefindingmightbeduetovariations
in smoking habits.
14 An analysis of combined cohorts
of 275000 nuclear workers from 15 countries who
were exposed to low, well documented doses of exter-
nal radiation did not show a significant association
between dose of radiation and either stroke or heart
disease.
15
With the exception of the study of US radiological
technologists, the studies were not able to adjust for
potential lifestyle factors or other confounding factors,
andsome ofthestudieshad noor onlycrudeestimates
of individual doses. Most of the studies of low doses
had limited statistical power and some potential for
bias;consequently,the potentialforbothfalse positive
and false negative results may be high. The United
NationsScientificCommitteeonthe Effects ofAtomic
Bomb Radiation (UNSCEAR) concluded that little
evidence, other than the atomic bomb studies, exists
to support an association between circulatory disease
and radiation in the dose range less than 1-2 Gy.
50 A
recent review article reached a similar conclusion,
51
although additional suggestively positive data have
appeared since these reviews were written.
131449
Mechanisms of circulatory disease
Knowledge of the mechanisms by which radiation
doses of 2 Gy or less may cause circulatory disease is
limited. Evidence suggests that pro-inflammatory
responses to radiation, cellular loss or functional
changes in the endothelium, or microvascular damage
may be early events in the cascade of pathogenic
changes that lead to radiation related heart
disease.
52-55 These may augment other risk factors,
such as hypertension, high serum cholesterol, smok-
ing, diabetes, and infection, to promote heart
disease.
56 Associations between dose of radiation and
long term levels of inflammatory markers have been
documentedamongatomicbombsurvivors,
36-38possi-
blybecauseofdamagetotheimmunesystem.
39Radia-
tion associated microvascular damage to the renal
parenchyma and vascular endothelial cells may pro-
mote hypertension and ischaemia.
5057
Conclusions and implications
The effect of radiation on risk of circulatory disease is
potentially a very important public health concern.
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graphy scans,
5859 and other relatively high dose diag-
nosticmedicalprocedures,aswellasradiotherapythat
exposestheheart,theimplicationsaresubstantialinso-
far as effects occur at doses under 1 Gy. The potential
magnitude of the risk is shown by the fact that in the
LifeSpanStudycohort,whoreceivedwholebodyirra-
diation, the radiation related excess of deaths from cir-
culatorydiseases(about210)isaboutathirdaslargeas
the total excess number of deaths from cancer (about
625).
Thisstudyprovidesthestrongestevidenceavailable
to date that radiation may increase the rates of stroke
andheartdiseaseatmoderatedoselevels(mainly0.5-2
Gy), but robust confirmatory evidence from other stu-
dies is needed. Although our results below 0.5 Gy are
not statistically significant, the additional cases occur-
ring with further follow-up time should provide more
precise estimates of the risk at low doses.
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